Raia Drogasil S.A. (RADL3.SA)
- Previous Close
15.30 - Open
0.00 - Bid 15.02 x --
- Ask 15.28 x --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 30.40 - Volume
0 - Avg. Volume
13,063,615 - Market Cap (intraday)
26.072B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
21.44 - EPS (TTM)
0.71 - Earnings Date Aug 5, 2025
- Forward Dividend & Yield 0.31 (2.07%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
22.51
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
rdsaude.com.br66,275
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RADL3.SA
View MorePerformance Overview: RADL3.SA
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RADL3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RADL3.SA
View MoreValuation Measures
Market Cap
26.07B
Enterprise Value
33.32B
Trailing P/E
21.43
Forward P/E
25.06
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.63
Price/Book (mrq)
4.02
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
10.71
Financial Highlights
Profitability and Income Statement
Profit Margin
2.95%
Return on Assets (ttm)
6.76%
Return on Equity (ttm)
18.68%
Revenue (ttm)
39.81B
Net Income Avi to Common (ttm)
1.17B
Diluted EPS (ttm)
0.71
Balance Sheet and Cash Flow
Total Cash (mrq)
470.18M
Total Debt/Equity (mrq)
118.73%
Levered Free Cash Flow (ttm)
1.36B